Valero Energy closed September 1 at $361.99 — above the consensus analyst price target of $319.63 — putting the Street in the uncomfortable position of defending ratings on a stock that has already blown through their numbers.
The most telling development this week is the analyst response to that gap. Wells Fargo's Sam Margolin raised his target to $389 on September 1, lifting it again from the $356 he set just a month earlier. That follows a cluster of post-earnings upgrades from late July: Goldman Sachs moved to $357, UBS to $355, and Barclays to $323. The problem is that even after these revisions, most targets still lag the current price. Mizuho and TD Cowen sit at $300 and $350 respectively, both below where the stock already trades. The consensus mean of $319 represents a roughly 12% discount to the market price — an unusual setup where the average analyst is effectively flagging overvaluation while maintaining ratings that range from Hold to Overweight. The bull case centres on Valero's vertically integrated model, its Diamond Green Diesel stake, and strong refining margins. Bears point to a stock up over 100% year-to-date, margin volatility risk, and geopolitical headwinds from the Iran conflict as reasons the recent run may be getting stretched.
The valuation data supports both readings simultaneously. The P/E multiple of 9.9x is modest in isolation, and EV/EBITDA of 7.1x has compressed roughly 1x over the past month — suggesting earnings have grown faster than the stock. Yet the price-to-book has ticked up to 3.4x over the same period, and the earnings yield of 10.1% reflects a market pricing in some mean reversion risk in refining margins. Factor scores add a useful layer: the analyst recommendation differential ranks in the 91st percentile of the universe, meaning Valero is unusually well-regarded relative to its short positioning — a divergence that typically points to institutional conviction underpinning the rally rather than momentum chasing.
Short positioning has continued the rebuild flagged in last week's note, though it remains far from extreme. Short interest now runs at 3.24% of the free float — up 8.5% over the past week and extending the move that began around August 24. In absolute terms, shorts held roughly 11 million shares in late July before covering aggressively through early August; the current 9.9 million represents a partial re-entry, not a fresh aggressive bet. The borrow market offers bears no friction whatsoever: availability remains extraordinarily loose at over 3,100% of current short interest, with 168 million shares available against fewer than 10 million borrowed. Cost to borrow has edged up 16% over the past week to 0.40% — notable as a directional move, but still negligible in absolute terms. The ORTEX short score of 36.5 is mid-range and essentially flat over the past ten days. None of this points to a squeeze setup or crowded short — it reads more like a modest valuation hedge being rebuilt as the stock pushes further above consensus targets.
Options positioning is close to neutral. The put/call ratio of 1.05 sits right at its 20-day average of 1.03, with a z-score near zero — essentially no incremental skew in either direction despite the week's 6.3% gain. That's a mild surprise given the price action. The 52-week PCR range runs from 0.61 to 1.78, so current readings are firmly in the middle of the historical band. Sector peers moved broadly in sympathy: MPC gained 7.9% on the week, PSX added 6.4%, and PBF led the group with a 12.7% move, suggesting a sector-wide bid rather than a VLO-specific re-rating.
The next scheduled earnings release is October 29. With the stock already trading above most analyst targets and short sellers slowly rebuilding at these levels, the October print becomes the natural arbitration point between the bull case on margins and the bear case on valuation.
See the live data behind this article on ORTEX.
Open VLO on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
